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Urolithiasis Location and Size and the Association
with Microhematuria and Stone-Related Symptoms
Costas D. Lallas, M.D., Xiaolong S. Liu, M.D., Allen N. Chiura, M.D.,
Akhil K. Das, M.D., and Demetrius H. Bagley, M.D.

Abstract

Purpose: To conduct a study to assess the association between calculus location and size and the incidence of
both microhematuria and symptoms of urolithiasis in a urology office environment.
Patients and Methods: After Institutional Review Board approval, a prospective study was conducted with data
from 100 consecutive patients who presented to our office with documented urolithiasis. The location (caliceal,
pelvic, or ureteral) and size ( < or ‡ 8 mm) of each calculus was determined from available diagnostic radiographs. The incidence of microhematuria was ascertained via a urine dipstick and microscopic examination. The
presence of any symptoms associated with urolithiasis, including pain, subjective fever or chills, or urinary
urgency, was recorded.
Results: A total of 111 stones were found in the study population resulting in a 45.9% incidence of microhematuria. In patients with renal pelvic and ureteral stones, 67.6% demonstrated microhematuria vs 36.4% with
caliceal stones, P = 0.0035. For stones ‡ 8 mm, 62.5% were positive for microhematuria vs 29.1% of stones < 8 mm,
P = 0.0006. Ureteral or renal pelvic stones caused the most symptoms (70.6%) compared with caliceal stones
(16.9%), P = 0.0001. In those patients who reported pain associated with urolithiasis, 65.6% had concomitant
microhematuria vs 36.8% in those without pain, P = 0.0097.
Conclusions: Urinary calculus location and size are associated with the incidence of microhematuria and stonerelated symptoms. Pain related to urolithiasis may be a positive predictor for the presence of microhematuria.

Introduction

T

he prevalence of urinary lithiasis has increased in the
United States during the past three decades.1,2 Approximately 10% to 15% of the US population will have an episode
of urolithiasis in their lifetime with recurrence rates as high as
50%.3 Epidemiologic studies have shown that whites are almost three times more likely to have urolithiasis compared
with blacks and men affected more often compared with
women.4,5 Other risk factors include a positive family history
and a variety of endocrine or metabolic abnormalities.6
Unfortunately, the occurrence of urinary lithiasis is not
always a benign entity. Most commonly, these stone episodes
can cause renal colic resulting in flank or abdominal pain,
urinary urgency or frequency, fevers or chills, nausea or
vomiting, and gross or microscopic hematuria.7,8 The incidence of microhematuria and urolithiasis has been estimated
to be as high as 90% in the literature and has been theorized
to be present when the patient’s pain is at its maximum intensity, diminishing to undetectable levels as the pain sub-

sides.9,10 The absence of hematuria, however, does not
always exclude the possibility of urinary lithiasis. Approximately 10% of patients may have a negative urine dipstick or
microscopic examination on initial presentation.11 Nevertheless, urolithiasis remains a consistent finding in those
undergoing workup for asymptomatic microhematuria and
can be the representing etiology in as many as 16.5% of
cases.12
Previous studies have attempted to stratify the incidence of
urinary lithiasis resulting in asymptomatic microhematuria to
differentiate a more significant stone from ones of less consequence (eg, ureteral stone vs a renal or vesical stone) and
have suggested a possible association between calculus location and the presence of microscopic hematuria.13,14
The majority of the studies evaluating the incidence of
microhematuria and urolithiasis have been limited to the
acute-care setting—specifically patients presenting for evaluation in hospital emergency departments.15–18 Our objective
was to perform a study to examine the incidence of microhematuria and urolithiasis-related symptoms and determine
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their possible association with the location and size of urinary
calculi in an ambulatory office environment.
Patients and Methods
After Institutional Review Board approval, a prospective
study was conducted by collecting data from 100 consecutive
patients (63 males and 37 females) who were evaluated at our
institution’s urology office who had received a diagnosis of
urolithiasis within a 6-month period. All patients had a
documented diagnosis of a urinary calculus via radiographic
imaging (eg, ultrasonography, radiography of the kidneys,
ureters, and bladder, urography, or CT). Patients who had a
documented urinary tract infection by a positive urinalysis
and urine culture or those who were actively menstruating
were excluded from the study.
The size and location of each calculus was determined
using both information from the radiology report as well as
evaluation by the office urologist with available imaging from
each patient’s respective diagnostic radiographs. Stone size
was categorized as either < 8 mm or ‡ 8 mm (cutoff represented the median stone size). The location of all urinary
stones was documented as renal calix (upper, mid, lower, or
unspecified), renal pelvis/ureteropelvic junction (UPJ), or
within the ureter (proximal or distal). Proximal ureteral stones
were those located proximal to the sacroiliac joint, and distal
ureteral stones were defined to be distal to this landmark.
None of the calculi were located in a diverticulum or within
the bladder.
Patients were interviewed with regard to their symptoms—
specifically, flank or abdominal pain, subjective fevers or
chills, or urinary urgency. Symptoms were recorded as
either present or absent, depending on patient response.
The presence of any of the aforementioned symptoms categorized the patient as positive for having stone-related
symptomatology.
One urine specimen was obtained from each patient during
the office visit. Each specimen was tested for blood using
Chemistrip 10 strips (Boehringer Mannheim Corporation,
Indianapolis, IN). A color grading system of ‘‘negative, trace,
1 + , 2 + , 3 + , 4 + ’’ was given with the product. ‘‘Trace’’ and
greater dipstick reactions were considered positive for microhematuria. In addition, approximately 5 mL of each urine
specimen was centrifuged at 2000 rpms for 5 minutes. One
drop of the resuspended pellet from the centrifuged urine was
placed on a slide with a coverslip and examined under a
microscope by a single urologist in the office. Between 10 and
15 high-power fields (at a magnification of 40 · ) were inspected for each sample. The maximum number of red blood
cells seen per high power field was noted. A patient was
considered to be positive for microhematuria if more than
three red blood cells per high power field were identified.
One physician interpreted both the urine dipstick and microscopic findings in all study patients. Those patients with
multiple stones were categorized as having microhematuria
in more than one stone category pending a positive result on
urine dipstick or microscopy. In addition, the negative microhematuria rate, defined as a calculus negative for blood by
either urine dipstick or microscopy, was also calculated.
Any patient with microscopic hematuria subsequently
underwent a standard urologic hematuria evaluation, including a contrasted upper tract imaging study, urine cytol-
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ogy, and cystoscopy to rule out any associated pathology
other than urolithiasis.
Statistical analysis was performed using the Fisher exact
test with a P value < 0.05 demonstrating statistical significance (GraphPad Prism Version 5.03, GraphPad Software, La
Jolla, CA).
Results
There were a total of 111 stones detected in the study
population. The location and size distribution of each stone is
shown in Table 1. In all, 69.4% of the stones were located in the
renal caliceal system and 30.6% in either the renal pelvis/UPJ
or ureter. The median stone size was 8 mm.
After examination by urine dipstick, the overall incidence
of microhematuria was 45.9% compared with 37.8% by urine
microscopy (Table 2). Stones in the renal pelvis/UPJ had the
highest incidence of microhematuria at 82.4% by urine dipstick vs 52.9% of ureteral stones and 36.4% of caliceal stones.
Comparable results are seen with microscopic analysis, because the rate of microhematuria was 76.5%, 52.9%, and 26%
for renal pelvis/UPJ, ureteral, and caliceal stones, respectively. In total, 67.6% of UPJ and ureteral calculi were dipstick
positive compared with 36.4% of all caliceal calculi, P = 0.0035.
By microscopic analysis, 64.7% of UPJ and ureteral calculi
were positive for microhematuria vs 26% of caliceal calculi,
P = 0.0002. The corresponding negative microhematuria rate
for renal pelvis/UPJ, ureteral, and caliceal stones is also reported (17.6%, 47.1%, and 63.6%, respectively), with the
highest percentage of negative stones located in a midcalix
(81.8%).
The incidence of stone-related symptoms in relation to the
location of urinary calculi is shown in Table 2. In total, 33.3%
of all stones contributed to patient symptoms relating to their
urolithiasis. Overall, 70.6% of ureteral and renal pelvic stones
resulted in the presence of one or more stone-related symptoms compared with 16.9% of all caliceal stones, P = 0.0001.
Proximal ureteral stones caused the highest rate of symptoms
(100%), while no symptoms were reported secondary to the
presence of midcaliceal stones.
Urolithiasis size and the incidence of microhematuria are
shown in Table 3. For stones ‡ 8 mm, the incidence of microhematuria via dipstick analysis was 62.5% compared with
29.1% for stones < 8 mm, P = 0.0006. By urine microscopy
51.8% vs 23.6% were positive for microhematuria in stones
‡ 8 mm and < 8 mm, respectively, P = 0.0032. The corresponding negative microhematuria rates were 70.9% for

Table 1. Distribution of Urolithiasis Based on Size
Location
Calix
Upper
Mid
Lower
Unspecified
RP/UPJ
Ureter
Proximal
Distal

< 8 mm

‡ 8 mm

7
3
26
5
0

5
8
18
5
17

4
10

0
3

RP = renal pelvis; UPJ = ureteropelvic junction.
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Table 2. Association Between Calculus Location and Incidence of Microhematuria
and Stone-Related Symptoms
Calculus location
Calix
Upper
Mid
Lower
Unspecified
RP/UPJ
Ureter
Proximal
Distal
Overall
P value +

( + ) Hematuria dipstick
4/12
2/11
19/44
3/10
14/17

(33.3%)
(18.2%)
(43.2%)
(30%)
(82.4%)

1/4 (25%)
8/13 (61.5%)
51/111 (45.9%)
0.0035

( + ) Hematuria micro
2/12
2/11
13/44
3/10
13/17

(16.7%)
(18.2%)
(29.5%)
(30%)
(76.5%)

1/4 (25%)
8/13 (61.5%)
42/111 (37.8%)
0.0002

( - ) Hematuria rate
8/12
9/11
25/44
7/10
3/17

(66.7%)
(81.8%)
(56.8%)
(70%)
(17.6%)

3/4 (75%)
5/13 (38.5%)
60/111 (54.1%)
0.0035

( + ) Symptoms
3/12
0/11
9/44
1/10
10/17

(25%)
(0%)
(20.5%)
(10%)
(58.8%)

4/4 (100%)
10/13 (76.9%)
37/111 (33.3%)
0.0001

+

P value calculated by comparing all ureteral/UPJ/RP stones vs all caliceal stones.
RP = renal pelvis; UPJ = ureteropelvic junction.

stones < 8 mm and 37.5% for those ‡ 8 mm. With regard to
patient symptomatology, 37.5% of stones ‡ 8 mm resulted in
the presence of patient symptoms compared with 29.1% of
stones < 8 mm, P = 0.4219 (Table 3).
In patients who specifically reported the presence of flank
or abdominal pain, 65.6% were positive for microhematuria
by urine dipstick compared with 36.8% for those without
pain, P = 0.0097 (Table 4). Of patients with urolithiasis-related
pain, 56.3% had a positive microscopic analysis compared
with 29.4% of patients without pain, P = 0.0147. The corresponding negative microhematuria rates were 34.4% and
63.2% for those with and without pain, respectively.
Discussion
Urinary lithiasis has been an escalating medical problem
with a yearly incidence of about 5% to 10% in North America
and Europe.19,20 True incidence is difficult to quantify, because most patients with asymptomatic stones may never
present for evaluation to the hospital or ambulatory setting.
The hallmark signs of an urolithiasis episode, including
renal colic, urinary urgency or frequency, fevers/chills, and
hematuria, account for more than half a million visits to the
emergency department yearly.11 To our knowledge, however,
the incidence of these findings has not been reported in the
nonacute setting. In our study of 100 consecutive office patients, we found that the overall majority of stones diagnosed
are asymptomatic (66.6%). The location of urinary lithiasis,
however, was associated with the presence of patient symptoms when they did occur. Those stones located in renal calices were the least symptomatic (16.9%) when compared with
renal pelvic (58.8%) or ureteral stones (82.4%). These findings
are consistent with those reported by Elton and associates21
who found unilateral flank pain to be the predominating

symptom in 89% of 206 emergency department patients with
a diagnosis of ureteral calculus.
Physiologic principles support these findings, because
ureteral calculi can result in urinary obstruction leading to
severe renal colic secondary to renal capsular expansion and
ureteral distention.16 In comparison, caliceal stones, assuming
they do not migrate into the renal pelvis or ureter, should be
the least symptomatic based on location and anatomy. There
was a trend toward an increase in patient symptoms in association with larger stone size, but this difference did not
reach statistical significance. In theory, larger stones in the
ureter may result in higher degrees of obstruction and possibly lead to more pain. Future studies should stratify stone
location based on size to determine if this perceived association exists with patient symptomatology.
Our results also indicate that the incidence of microhematuria by both urine dipstick and microscopic examination is associated with both calculus location and size. Stones
located in the renal pelvis/UPJ and ureter were approximately twice as likely to cause microhematuria compared with
those in the renal caliceal system. The exact mechanism of
ureteral or UPJ stones leading to a higher incidence of microhematuria is difficult to elucidate, although the increased
possibility of urothelial irritation or local inflammation is
certainly related, and is corroborated by our stone location
and patient symptom findings.
With regard to size, stones ‡ 8 mm were more than twice as
likely to be associated with microhematuria as those < 8 mm by
either urine dipstick or microscopic examination. This finding
is particularly interesting given results from previous studies
using 6 mm as a cutoff value that reported no difference in the
rate of microhematuria based on calculus size alone.18
Our overall microhematuria rate was 45.9%, which is significantly lower than the 91% reported by Li and colleagues11 in

Table 3. Association Between Calculus Size and Incidence of Hematuria and Related Symptoms
Calculus size
< 8 mm
‡ 8 mm
P value

( + ) Hematuria dipstick

( + ) Hematuria micro

( - ) Hematuria rate

( + ) Symptoms

16/55 (29.1%)
35/56 (62.5%)
0.0006

13/55 (23.6%)
29/56 (51.8%)
0.0032

39/55 (70.9%)
21/56 (37.5%)
0.0006

16/55 (29.1%)
21/56 (37.5%)
0.4219
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Table 4. Association Between Hematuria and Pain
Pain

( + ) Hematuria
dipstick

( + ) Hematuria
micro

( - ) Hematuria
rate

Present
Absent
P value

21/32 (65.6%)
25/68 (36.8%)
0.0097

18/32 (56.3%)
20/68 (29.4%)
0.0147

11/32 (34.4%)
43/68 (63.2%)
0.0097

their series of 159,000 patients. Their study, however, was
conducted as a retrospective review of patients who presented
in the acute environment (ie, the emergency department) for
evaluation of urolithiasis with the great majority of their stones
(76%) located at the ureterovesical junction or in the ureter,
which may have lead to their higher overall rate of microhematuria. In comparison, 61.5% of our patients with distal
ureteral stones were positive for microhematuria, which more
closely resembles the results from their study population.
We report the incidence of microhematuria with both urine
dipstick as well as microscopic examination in this study.
Neither test is without its inherent flaws. False-positive urine
dipstick results can occur secondary to hemoglobinuria,
myoglobinuria, or contaminants such as hypochlorite or
povidone-iodine.22 Red cell hemolysis, interobserver variability, and poor reliability can lead to false negative or positive
results using urine microscopy alone.23,24 Our results note a
higher incidence of microhematuria using urine dipstick when
compared with microscopy. Other authors, however, have
reported on the reliability of urine dipstick analysis for microhematuria, stating that a negative dipstick followed by a positive microscopic examination only added 2% to the diagnostic
accuracy of urine dipstick in a study of 609 patients with urolithiasis.18 It is important to note that both urine dipstick and
microscopy yielded statistically significant results in our study,
indicating that the association between the incidence of
microhematuria and stone location and size exists regardless of
test method interpreted.
The presence of pain may be an independent predictor of
microhematuria. Patient report of pain was associated with a
statistically significant higher incidence of microhematuria by
either urine dipstick (65.6%) or microscopic examination
(56.3%). Although a direct link between pain and microhematuria is difficult to surmise, we again postulate that
stones located in the ureter or UPJ may lead to more urothelial
irritation and thus higher rates of microhematuria in this
population.
Our absolute rates of microhematuria and patient reported
symptoms are lower than those reported in the literature.
Patients in our study were evaluated in the ambulatory office,
a nonemergent setting, which inherently drives these values
lower when compared with other studies based on findings
during acute stone episodes. Thus, differences in the incidence
of microhematuria and stone-related symptoms may have
been more apparent given our patient population. In addition,
specific urine dipstick results (ie, the number of patients with
trace, 1+, 2+, 3+, 4+) and long-term follow-up data of
asymptomatic microhematuria patients were not available for
analysis. It would be interesting to investigate this in future
studies and determine if the amount of microhematuria was
associated with stone location or size or the occurrence of
future symptomatic episodes in those who were initially
asymptomatic.

Conclusion
In the ambulatory setting, microhematuria is not a universal finding in patients with urinary calculi and varies with
stone location and size. The presence of pain may be an independent predictor of microhematuria in these patients with
urolithiasis.

Disclosure Statement
No competing financial interests exist.
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